Vol. 4 No. 3 (2026), Articles
Vol. 4 No. 3 (2026)

BRONXIAL ASTMA VA UNING DIFFERENSIAL DIAGNOSTIKASI

Articles
Published 2026-03-27
Toshtemirova Muxlisa Irgash qizi
Termiz Iqtisodiot va Servis Universiteti tibbiyot fakulteti Davolash ishi ta'lim yo‘nalishi
PDF
DOI

Keywords

bronxial astma, yallig‘lanish, havo yo‘llari remodellingi, allergik reaktsiyalar, genetik predispozitsiya, immun hujayralar, sitokinlar, bronxodilatatorlar, kortikosteroidlar, biologik davolash, individualizatsiyalangan terapiya, surunkali kasallik boshqaruvi

How to Cite

BRONXIAL ASTMA VA UNING DIFFERENSIAL DIAGNOSTIKASI. (2026). MEDICINE, PEDAGOGY AND TECHNOLOGY: THEORY AND PRACTICE, 4(3), 82-90. https://universalpublishings.com/~niverta1/index.php/mpttp/article/view/17351
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Bronxial astma - bu surunkali yallig‘lanish bilan kechadigan          nafas  yo‘llarini torayishi bo‘lib, bronxospazm va mukus ishlab chiqarishning ortishi bilan xarakterlanadi. Astma ko‘pincha nafas qisilishi, yo‘tal, ko‘krak qismida og‘irlik va shovqinli nafas olish bilan namoyon bo‘ladi. Ushbu kasallik butun dunyo bo‘yicha keng tarqalgan bo‘lib, har qanday yoshdagi insonlarda uchrashi mumkin. Astmaning paydo bo‘lishida genetik omillar, atrof-muhit sharoitlari va immunologik mexanizmlar o‘zaro ta’sir ko‘rsatadi. Ushbu maqolada bronxial astmaning kelib chiqish sabablari, asosiy patogenez mexanizmlari, shuningdek zamonaviy  davolash  usullari  keng  qamrovli  tahlil qilindi. Tadqiqotlar allergenlar, genetik predispozitsiya, atrof-muhit omillari va immunologik reaktsiyalarni bronxial astma rivojlanishidagi asosiy omillar sifatida ko‘rsatadi. Maqolada yallig‘lanish jarayonining molekulyar va hujayra asoslari, sitokinlar va immun hujayralar roli,          havo yo‘llaridagi          remodeling mexanizmlari batafsil yoritilgan. Shuningdek, bronxial astma terapiyasida bronxodilatatorlar, kortikosteroidlar, biologic preparatlar, individual davolash  strategiyalari  samaradorligi  tahlil qilindi. Ushbu ish klinik va ilmiy jihatdan bronxial astmani boshqarish bo‘yicha hozirgi zamonaviy yondashuvlarni birlashtirib, bemorlar uchun individualizatsiyalangan terapiya imkoniyatlarini ko‘rsatadi.

PDF
DOI

References

Mustafayev I.A., Quliyeva N.M., Ibrahimova Sh.H., Faramazov A.Z. “Assessment of Cytokine Status Depending on the Stage of Bronchial Asthma in Children.” Azərbaycan Allerqologiya və Klinik İmmunologiya Jurnalı, 2023; 11(1).

2. Sahnoon L., Bajbouj K., Mahboub B., Hamoudi R. “Targeting IL-13 and IL-4 in Asthma: Therapeutic Implications on Airway Remodeling in Severe Asthma.” Clinical Reviews in Allergy & Immunology, 2025.

3. “Inflammation in Asthma: Mechanistic Insights and the Role of Biologics in Therapeutic Frontiers.” Biomedicine & Pharmacotherapy, 2023 (yoki yaqinda nashr qilingan sharh maqolasi).

4. “Evidence Based Approach of Biologic Therapy in Bronchial Asthma.” Journal of Clinical Medicine (MDPI), 2022.

5. «Bronxial astmaning turli shakllarida immunologik ko’rsatgichlar tahlili» — X.I. Turdibekov va boshqalar. Science and Education, 2006.

6. “Bolalarda bronchial astmaning klinik, immunologik va mikrobiologik aspektlari. Olib borish taktikasi.” Journal of Science-Innovative Research in Uzbekistan, 2024.

7. “Bolalarda bronxial astma: diagnostikada va davolashda qiyinchiliklar.” Modern Education and Development, 2024.

8. “Bronxial astma kasalligi va uni davolash yo’llari.” — Y. M. Ahmedova, I. A. Ergasheva. 2023. Ilmiy maqola (rus/ozbek).

9. “Bronxial astma kasalligini erta aniqlash va oldini olish choralari.” — F.O. Tursunov, L. Nurmuhammadiyeva, H. Rajabova. Journal-web.uz, 2025.

10. “Recent developments in the use of biologics targeting IL-5, IL-4, or IL-13 in severe refractory asthma.” PubMed review, 2018.